You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

G12D

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Ductal Adenocarcinoma Trial in New York (VSV-GP154, ATP150, ATP152)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • New York, New York
    NYU Langone Health
May 4, 2023

Solid Tumor, Advanced Solid Tumor, NSCLC Trial (MRTX1133)

Not yet recruiting
  • Solid Tumor
  • +4 more
  • (no location specified)
Feb 21, 2023

Pancreatic Ductal Adenocarcinoma, Colorectal Cancer, NSCLC Trial (ELI-002 7P)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +14 more
  • ELI-002 7P
  • (no location specified)
Feb 3, 2023

Solid Tumor, Adult, EphA2 Overexpression, KRAS G12V Trial in Beijing (KRAS-EphA-2-CAR-DC, Abraxane, Cyclophosphamide)

Recruiting
  • Solid Tumor, Adult
  • +4 more
  • KRAS-EphA-2-CAR-DC
  • +3 more
  • Beijing, Beijing, China
    Biotherapeutic Department of Chinsese PLA Gereral Hospital
Nov 29, 2022

Minimal Residual Disease, KRAS G12D, KRAS G12R Trial in United States (ELI-002 2P)

Recruiting
  • Minimal Residual Disease
  • +11 more
  • ELI-002 2P
  • Duarte, California
  • +10 more
Jan 18, 2023

NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +32 more
  • (no location specified)
Mar 30, 2023

Slow-Flow Vascular Malformation, Fast-Flow Vascular Malformation, Vascular Malformations Trial in Parkville (Alpelisib,

Not yet recruiting
  • Slow-Flow Vascular Malformation
  • +17 more
  • Parkville, Victoria, Australia
    The Royal Children's Hospital
Aug 7, 2023

Advanced Solid Tumor, NSCLCs Trial in Houston (Adagrasib, Olaparib)

Not yet recruiting
  • Advanced Solid Tumor
  • Non-small Cell Lung Cancers
  • Houston, Texas
    M D Anderson Cancer Center
Nov 15, 2023

Metastatic Pancreatic Cancer Trial in Houston (MRTX849)

Not yet recruiting
  • Metastatic Pancreatic Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Nov 22, 2022

KRAS P.G12C Trial in Worldwide (D3S-001)

Recruiting
  • KRAS P.G12C
  • Detroit, Michigan
  • +12 more
Jan 16, 2023

Pancreas Cancer Trial in Scottsdale (Vemurafenib, Sorafenib)

Recruiting
  • Pancreas Cancer
  • Scottsdale, Arizona
    HonorHealth Research Institute
Oct 28, 2021

Lung Cancer, Gastro-intestinal Cancer Trial in Houston (Durvalumab, Adagrasib)

Not yet recruiting
  • Lung Cancer
  • Gastro-intestinal Cancer
  • Houston, Texas
    M D Anderson Cancer Center
May 9, 2023

Solid Tumor Trial in United States (ASP3082)

Recruiting
  • Solid Tumor
  • Santa Monica, California
  • +10 more
Jan 6, 2023

Lung Cancer Trial in Houston (AMG 510, Cisplatin, Carboplatin)

Recruiting
  • Lung Cancer
  • AMG 510
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 10, 2022

NSCLC Trial in Shanghai, Hangzhou (D-1553, Other)

Not yet recruiting
  • NSCLC
  • Shanghai, Shanghai, China
  • +1 more
Aug 11, 2022

Real-life: Impact on Adherence and Health Status (TRITRIAL)

Completed
  • COPD
  • BDP/FF/G fixed combination
  • Rome, Italy
    Fondazione Policlinico Gemelli
May 4, 2022

NSCLC (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC) Trial in San Antonio, Fairfax (RMC-9805)

Recruiting
  • Non-small Cell Lung Cancer (NSCLC)
  • +3 more
  • San Antonio, Texas
  • +1 more
Sep 8, 2023

Smoking, Tobacco Use Trial in High Point (ENDS Product A with 1.5% nicotine, ENDS Product B with 1.5% nicotine, ENDS Product C

Completed
  • Smoking
  • Tobacco Use
  • ENDS Product A with 1.5% nicotine
  • +7 more
  • High Point, North Carolina
    High Point Clinical Trials Center
Jun 23, 2022

NSCLC Stage III, KRAS P.G12C Trial in Spain (Sotorasib)

Recruiting
  • Non-small Cell Lung Cancer Stage III
  • KRAS P.G12C
  • Badalona, Barcelona, Spain
  • +19 more
Jul 6, 2022

Glioblastoma Trial in Spain (TN-TC11G, Temozolomide Oral Product, Radiotherapy)

Not yet recruiting
  • Glioblastoma
  • L'Hospitalet de Llobregat, Barcelona, Spain
  • +7 more
Aug 2, 2022

Advanced Solid Tumors, Colorectal Cancer, Non Small Cell Lung Cancer Trial in France, Spain (CAN04 (nadunolimab), mFOLFOX, DTX)

Active, not recruiting
  • Advanced Solid Tumors
  • +3 more
  • CAN04 (nadunolimab)
  • +3 more
  • Saint-Herblain, Boulevard Jacques Monod, France
  • +5 more
Oct 20, 2022

Diabetic Peripheral Neuropathy Trial in Jedda (Group- A (100% weight-bearing; n=14), (moderate-intensity (50-70% heart rate

Completed
  • Diabetic Peripheral Neuropathy
  • Group- A (100% weight-bearing; n=14), (moderate-intensity (50-70% heart rate reserve) aerobic exercise training on the antigravity treadmill, 3 times/week for 12-weeks.
  • +4 more
  • Jedda, Saudi Arabia
    Umm Al-Qura University
Sep 29, 2022

Locally Advanced or Metastatic Renal Cell Carcinoma Trial in Worldwide (Cabozantinib)

Active, not recruiting
  • Locally Advanced or Metastatic Renal Cell Carcinoma
  • Salzburg, Austria
  • +39 more
Jan 18, 2023

NSCLC Stage IV, KRAS P.G12C Trial in Worldwide (Adagrasib)

Not yet recruiting
  • NSCLC Stage IV
  • KRAS P.G12C
  • Brussels, Belgium
  • +26 more
Jan 3, 2023

NSCLC Trial in United States (Bortezomib, Acyclovir)

Completed
Has Results
  • Non-Small Cell Lung Cancer
  • Basking Ridge, New Jersey
  • +4 more
Jul 22, 2020